Follow
Andrew W Shaw
Andrew W Shaw
Spark Therapeutics
Verified email at sparktx.com
Title
Cited by
Cited by
Year
Thermotropic phase transition in soluble nanoscale lipid bilayers
IG Denisov, MA McLean, AW Shaw, YV Grinkova, SG Sligar
The Journal of Physical Chemistry B 109 (32), 15580-15588, 2005
2092005
Evaluation of efficacy, biodistribution, and inflammation for a potent siRNA nanoparticle: effect of dexamethasone co-treatment
MT Abrams, ML Koser, J Seitzer, SC Williams, MA DiPietro, W Wang, ...
Molecular therapy 18 (1), 171-180, 2010
2032010
The local phospholipid environment modulates the activation of blood clotting
AW Shaw, VS Pureza, SG Sligar, JH Morrissey
Journal of Biological Chemistry 282 (9), 6556-6563, 2007
1902007
Phospholipid phase transitions in homogeneous nanometer scale bilayer discs
AW Shaw, MA McLean, SG Sligar
FEBS letters 556 (1-3), 260-264, 2004
1762004
Microfluidic patterning of nanodisc lipid bilayers and multiplexed analysis of protein interaction
ED Goluch, AW Shaw, SG Sligar, C Liu
Lab on a Chip 8 (10), 1723-1728, 2008
422008
Adeno-associated virus (aav) vector lipid nanoparticle compositions and methods of use
AW Shaw, X Anguela
US Patent App. 15/733,246, 2021
2021
Protein-Lipid Interactions in Soluble Nanoscale Lipid Bilayers
AW Shaw
University of Illinois at Urbana-Champaign, 2007
2007
Molecular sensing using silicon nanopores
C Ho, JB Heng, R Timp, O Aksimentiev, K Schulten, A Shaw, S Sligar, ...
BIOPHYSICAL JOURNAL 86 (1), 481A-481A, 2004
2004
The system can't perform the operation now. Try again later.
Articles 1–8